YUN J. TSO,MARNA WILLIAMS,DAVID B. POWERS,GAO LIU,NICOLAS F. LANDOLFI
申请号：
PT10183377
公开号：
PT2371391E
申请日:
2004.05.10
申请国别(地区):
PT
年份:
2014
代理人:
摘要：
The present disclosure is directed to antagonists of CS1 that bind to and neutralize at least one biological activity of CS1. The disclosure also includes a pharmaceutical composition comprising such antibodies or antigen-binding fragments thereof. The present disclosure also provides for a method of preventing or treating disease states, including autoimmune disorders and cancer, in a subject in need thereof, comprising administering into said subject an effective amount of such antagonists.
